Apomorphine Pump in Early Stage of Parkinson's Disease (EARLY-PUMP)
Status:
Recruiting
Trial end date:
2025-06-30
Target enrollment:
Participant gender:
Summary
The aim of the study is to assess the use of the apomorphine pump in earlier stages of
Parkinson' Disease (PD), when motor complications have just developed and before patients are
significantly affected in their social and occupational functioning. The investigators
hypothesize that apomorphine pump is superior in terms of positive impact on quality of life
(QoL) to oral medical therapy alone at a relatively early stage of PD, before the appearance
of severe disabling motor complications thus favoring the maintain of patients' social and
occupational status with a significant positive economic impact of the health system.